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This study sought to determine whether models of cerebrovascular function based on
Laguerre-Volterra kernels that account for nonlinear cerebral blood flow (CBF) dynamics
can detect the effects of functional cerebral sympathetic blockade. We retrospectively
analyzed continuous beat-to-beat blood pressure, middle cerebral blood velocity, and
partial-pressure of end-tidal CO2 (PETCO2) recordings from eighteen healthy individuals
who were treated with either an oral dose of the α1-adrenergic receptor blocker Prazosin
or a placebo treatment. The global principal dynamic modes (PDMs) were analyzed
using Laguerre-Volterra kernels to examine the nonlinear system dynamics. Our principal
findings were: (1) very low frequency (<0.03Hz) linear components of first-order kernels
for BP and PETCO2 are mutually coupled to CBF dynamics with the ability to separate
individuals between control and blockade conditions, and (2) the gains of the nonlinear
functions associated with low-pass and ≈0.03Hz global PDMs for the BP are sensitive
to sympathetic blockade. Collectively these results suggest that very low frequency
global PDMs for BP may have potential utility as functional biomarkers of sympathetic
neurovascular dysfunction which can occur in conditions like autonomic failure, stroke
and traumatic brain injury.
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1. INTRODUCTION
Biomarkers of sympathetic cerebrovascular dysfunction have proved difficult to identify owing
to the linear and stationary assumptions of conventional haemodynamic modeling techniques
(Zhang et al., 1998; Hamner et al., 2010). To address this issue, different approaches have recently
been proposed that can either identify or explicitly account for nonlinear (Mitsis et al., 2009)
and nonstationary (Latka et al., 2005) characteristics of cerebral haemodynamics (Peng et al.,
2008; Saleem et al., 2016). An important class of these methods include the novel approach of
principal dynamic modes (PDMs), in connection with the kernels of Laguerre-Volterra models,
that was introduced by Marmarelis (1997, 2004) in order to quantify the nonlinear dynamics of
relationships between blood pressure (BP), cerebral blood flow (CBF) and other covariate inputs
e.g., partial-pressure of end-tidal CO2 (PETCO2) (Mitsis et al., 2002, 2004, 2005).
Several recent studies have utilized these models (i.e., PDMs and Laguerre-Volterra
kernels Marmarelis, 1997, 2004) as methods for detecting states of physiological impairment
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(Marmarelis et al., 1993; Chon et al., 1994; Mitsis et al.,
2006; Zanos et al., 2008; Kang et al., 2015). For example,
Kang et al. (2015) showed differential temporal relationships
between frontal and occipital electroencephalogram (EEG)
signals in Alzheimer’s patients compared to healthy individuals.
In contrast, Mitsis et al. (2009) modeled CBF responses to
BP and PETCO2 fluctuations in healthy individuals using
Laguerre-Volterra kernels before and after ganglionic blockade.
A significant increase in spectral power of the first-order kernel
in the very low frequency range (<0.04Hz) was detected,
suggesting that the autonomic nervous system is modulator
of very slow components of CBF regulation. However, that
study focused only on the Volterra kernels and did not
examine PDMs. Moreover, it has been hypothesized that the
spectral characteristics of the global PDMs and the gains
of subject-specific associated nonlinear functions (ANFs) may
reflect information about specific autoregulatory mechanisms
(Marmarelis et al., 2012, 2013a, 2014). For example, the blunted
vasomotor reactivity in mild cognitive impaired individuals
affected the slope of associated nonlinear function of PDMhaving
low-pass characteristics (Marmarelis et al., 2014). But whether
these model-based indices can function as targeted biomarkers
of cerebrovascular sympathetic control remains unclear due
to the lack of data collected under controlled experimental
conditions.
Here we seek to determine whether global PDMs can
detect the attenuation of cerebrovascular control induced by
targeted functional sympathetic blockade. To achieve this we
analyzed spontaneous BP, PETCO2, and CBF signals recorded
from healthy individuals before and after pharmacological α1-
adrenergic receptor blockade. The intrinsic nonlinear dynamics
of the underlying relations were examined using Laguerre-
Volterra based first- and second-order kernels. Further, we
extended the kernel approaches by applying the notion of global
PDMs that can be passed through ANFs (Marmarelis et al.,
2012, 2013a, 2014). Collectively this approach allowed us to
explicitly characterize nonlinear dynamics which is not possible
using methods like transfer function and wavelet decomposition
analysis (Saleem et al., 2016). We hypothesized that (1) very
low frequency linear components (defined by the first-order
kernels) of the BP and PETCO2 are mutually coupled, and (2)
the gains of the ANFs of very low frequency global PDMs for
the BP can discriminate between intact and impaired states of
sympathetic neurovascular control. Our findings suggest that
global PDMs and ANFs gains may have potential utility as
functional biomarkers of neurovascular impairment associated
with adrenergic dysfunction; a key pathogenic mechanism for
poor outcomes in conditions like autonomic failure, stroke
(Korpelainen et al., 1999), and traumatic brain injury (Takahashi
et al., 2014).
2. DATA COLLECTION AND PROCESSING
METHODS
All experimental protocols were performed according to the
standards set by the Declaration of Helsinki and were approved
by the New Zealand Central Regional Ethics Committee
[approval number: CEN/09/10/072].
2.1. Participants
We performed retrospective analysis of data collected from 18
subjects after getting a written informed consent from each
subject to participate in this study. None of the subjects had taken
caffeine-containing products and heavy exercise for at least 12 h
prior to the study, and all were instructed to have a light breakfast
at least 2 h before the study. Only healthy subjects with no regular
medication and having no known history of any cardiovascular,
respiratory or neurological diseases were recruited for this
study.
2.2. Measurements
As reported previously (Saleem et al., 2016), the continuous
electrocardiogram, non-invasive blood pressure via finger
photoplethysmography (Finometer MIDI, MLE1054-V, Finapres
Medical Systems, Amsterdam, The Netherlands), right middle
cerebral artery blood flow velocity (MCAv; 2MHz pulsed
Doppler ultrasound, ST3 Digital Transcranial Doppler (TCD)
System, Spencer Technologies, Seattle, WA), and partial-
pressure of end-tidal CO2 sampled from a face mask (gas
analyzer model ML206, ADInstruments, Colorado Springs,
CO, USA) were recorded continuously at 1 kHz per channel
via an analog-to-digital converter (PowerLab/16SP ML795;
ADInstruments) interfaced with a computer. The recorded
signals were stored on a computer for off-line analysis using
LabChart 7 Pro (ADInstruments, Colorado Springs, CO,
USA).
2.3. Experimental Protocols
All experimental protocols were performed with participants
lying in the supine position. The experiments were performed
between 9 am and 12 noon in a quiet, temperature- and
humidity-controlled laboratory (22–23◦C). After acclimatization
to the laboratory environment, 6 min of baseline resting
data were recorded before the administration of placebo pill
(9 subjects with 6 females, age: 21–26 years) or 0.05mg/Kg
oral Prazosin (9 subjects with 5 females, age: 21–26 years).
To coincide with the peak pharmacodynamic activity on the
cerebrovasculature, the post-ingestion protocols were repeated
after 120min which have previously (Jaillon, 1980) been observed
to block ≈80% of the pressor response to phenylephrine
in healthy normotensive subjects of similar age and body
mass index to those of the current study. Participants
were free to move around the laboratory, but were not
allowed to eat or drink during the post-ingestion period of
120 min.
2.4. Data Pre-processing
Beat-to-beat mean arterial BP, mean MCAv values and breath-
to-breath PETCO2 time series were determined from the
recorded continuous BP, MCAv (an index of CBF) and PETCO2
waveforms. These beat-to-beat signals were then interpolated
using cubic spline before decimating to 1Hz. Occasional
measurement artifacts were identified and removed using
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Grubb’s test. Next, a fifth-order Butterworth filter with a
cut-off frequency of 0.005Hz was employed to remove the
very slow dynamics and baseline drift of the time series. To
remove transient artifacts associated with data filtering, the
initial and last segments (equal to the filter length which is
5 in the current study) of data were ignored for subsequent
analyses. All data pre-processing and analyses were performed
using a custom written software in MATLAB (version R2014b;
Mathworks).
2.5. Statistics
All values are presented as mean ± standard error, unless
otherwise stated. The normality of the data was determined
using the Shapiro-Wilk’s test. For ease of interpretation and
analysis, all values and confidence intervals are presented in
standard units. Linear mixed-effects models were employed to
determine differences between placebo and sympathetic blockade
groups by specifying a main effect for the condition (pre-
vs. post-blockade), a main effect for the group (placebo vs.
sympathetic) and a condition × group interaction. Statistically
significant two-way (condition × group) interactions show
that the sympathetic blockade effects were different from
the placebo treatment. Paired-t tests were performed for
post-hoc pairwise comparisons to determine the significant
difference between pre- and post-blockade responses. All data
were pooled for statistical analysis because there were no
gender interactions. The significance level for Grubb’s test
was set at 0.95. Statistical significance was set a priori at
p< 0.05.
2.6. Principal Dynamic Modes Analysis
The intrinsic nonlinear dynamics of BP and MCAv fluctuations
have been examined with the use of Laguerre-Volterra
kernels based PDM analysis in recent studies (Mitsis et al.,
2009; Marmarelis et al., 2012, 2013a). Briefly, the proposed
methodology starts with the estimation of first- and second-
order (self and cross) Volterra kernels using Laguerre expansions
from the given inputs (BP and PETCO2) and output (MCAv).
These first- and second-order self-kernels of all subjects (of both
pre- and post-blockade conditions) are combined to form a
rectangular matrix that is used to compute the global PDMs via
singular value decomposition. The resulting global PDMs form a
filter bank where each filter generates the signal (via convolution
of each input signal with the respective global PDM) which is
subsequently passed through an associated nonlinear function.
The intermodulatory interactions among the inputs can be
included by computing the cross-kernels and pair-products
of PDM outputs (Marmarelis et al., 2013a). Collectively, the
polynomial transformed PDM outputs of both inputs and the
cross-terms form the system output (MCAv). The mathematical
relations of the above described methodology are given
below.
The second-order Volterra model for the dual input
(BP + PETCO2 − MCAv) system of cerebral hemodynamics
(Mitsis et al., 2009) can be written as,
F(n) = k0 +
M∑
m1
kP(m1)P(n−m1)+
M∑
m2
kC(m2)C(n−m2)
+
M∑
m1
M∑
m2
kPP(m1,m2)P(n−m1)P(n−m2)
+
M∑
m1
M∑
m2
kCC(m1,m2)C(n−m1)C(n−m2)
+
M∑
m1
M∑
m2
kPC(m1,m2)P(n−m1)C(n−m2)
+ ǫ(n), (1)
where P, F, and C are BP, MCAv and PETCO2 respectively, k0
is a zeroth-order kernel (a constant),
{
kP, kC
}
are first-order
kernels of P and C respectively, {kPP, kCC and kPC} respectively
are second-order self- and cross-kernels describing the nonlinear
interactions of P and C at time lags (m1,m2), and ǫ(n) includes
the effects of measurement or modeling errors.M is the order of
the system memory. It is assumed that M has the same value for
each series expansion term for Equation (1).
First- and second-order kernels of the BP and PETCO2 inputs
for each subject can be estimated using orthonormal Laguerre
functions
{
bj, j = 1, ..., L
}
. The kernels estimated in this way
include exponential decay which is consistent with the dynamic
characteristics of the physiological systems (Marmarelis, 2004)
and can be written as Kang et al. (2015),
kP(m1) =
L∑
j1 = 1
βP(j1)bj1(m1), (2)
kC(m2) =
L∑
j1 = 1
βC(j1)bj1(m2), (3)
kPP(m1,m2) =
L∑
j1 = 1
j1∑
j2=1
βPP(j1, j2)bj1(m1)bj2(m2), (4)
kCC(m1,m2) =
L∑
j1 = 1
j1∑
j2=1
βCC(j1, j2)bj1(m1)bj2(m2), (5)
kPC(m1,m2) =
L∑
j1 = 1
j1∑
j2=1
βPC(j1, j2)bj1(m1)bj2(m2), (6)
where the Laguerre functions are given by Mitsis andMarmarelis
(2002),
bj(m) = α
(m− j)/2(1− α)1/2
j∑
k= 0
(−1)k
(
m
k
)(
j
k
)
αj− k(1− α)k,
(7)
with a parameter α which determines the asymptotic exponential
decay rate. In this study the same value of α, and the
same number of Laguerre functions (i.e., L) are employed for
estimation of kernels (both BP and PETCO2 inputs) as defined
in Equations (2–7), and β =
[
β0 βP βPP βC βCC βPC
]
are the
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expansion coefficients estimated using the ordinary least-square
technique (Kang et al., 2015) i.e.,
β = (VTV)−1VF, (8)
with,
V =
[
I VP VC VPP VCC VPC
]
, (9)
where I is a S× 1 unit vector (containing 1s) and VP, VC (each a
S× Lmatrix) are given by,
VP =
[
b1 ∗ P b2 ∗ P · · · bL ∗ P
]
, (10)
VC =
[
b1 ∗ C b2 ∗ C · · · bL ∗ C
]
, (11)
and each of VPP, VCC and VPC is a S × L(L+ 1)/2 matrix
with columns defined by the complete set of L(L+ 1)/2 unique
pairs of
(
bj1 ∗ P
)
⊙
(
bj2 ∗ P
)
,
(
bj1 ∗ C
)
⊙
(
bj2 ∗ C
)
and
(
bj1 ∗ P
)
⊙(
bj2 ∗ C
)
, respectively, with j1 = 1, ..., L and j2 = 1, ..., j1.
The notation ∗ represents convolution and ⊙ represents the
Hadamard product. S = T − 1 where T is the data length of
each input (BP or PETCO2), and F is the output MCAv.
The minimum set of basis functions, namely Principal
Dynamic Modes (PDMs) (Marmarelis et al., 2012, 2013a), that
can represent the BP+ PETCO2 to MCAv dynamics adequately is
determined via the singular value decomposition of a rectangular
matrix containing the estimated first- and second-order (self)
kernels of all subjects of both (pre- and post-blockade) conditions
of a specific group (i.e., sympathetic blockade or placebo
treatment) for each input, given as,
Q = UλV⋆. (12)
Here,
Q =
[
kc1,1 σ
c
1 × k
c
2,1 · · · k
c
1,N σ
c
1 × k
c
2,N
kb1,1 σ
b
1 × k
b
2,1 · · · k
b
1,N σ
b
1 × k
b
2,N
] (13)
is a rectangular matrix where kc1,N is a first-order kernel (in
the form of a column vector) and kc2,N is a second-order self-
kernel (in the form of a block matrix) multiplied by the standard
deviation of the respective input [i.e., σ cN for the Nth subject
for one input (BP or PETCO2)]. The superscripts c and b
correspond to pre- and post-blockade conditions, respectively.
For subsequent analyses we have made use of matrix U (of
equation 12 instead of matrix V) to derive global PDMs
because the columns of matrix U show similar characteristics
across subjects. The singular vectors (the columns of matrix
U) corresponding to the significant singular values (of diagonal
matrix λ) form the global PDMs (i.e., gi,p or gi,c in Equation
14) for the respective input (BP or PETCO2), and are used to
describe the dynamics of the underlying (BP – MCAv or PETCO2
– MCAv) relationships. The resulting global PDMs form a filter
bank where each filter takes in the input and provides an output
signal which is subsequently passed through a nonlinear function
(i.e., fi,p or fi,c in Equation 14) to form the system output. The
output equation for the dual-input PDM based model is given by
Marmarelis et al. (2013a, 2014),
F(n) =
H∑
i= 1
fi,p


M− 1∑
m1 = 0
gi,p(m1)P(n−m1)


+
H∑
i= 1
fi,c


M− 1∑
m2 = 0
gi,c(m2)C(n−m2)


+
M− 1∑
m1 = 0
M− 1∑
m2 = 0
gi,p(m1)gi,c(m2)P(n−m1)C(n−m2)
︸ ︷︷ ︸
cross-terms
+ ǫ(n), (14)
where gi,p, gi,c are the ith global PDMs for the BP and PETCO2
inputs respectively, H is the number of the global PDMs, and
fi,p, fi,c are the nonlinear functions associated with each global
PDM gi,p, gi,c respectively, termed associated nonlinear functions
(ANFs), generally given in a polynomial form as Kang et al.
(2015),
fi(u) = a1u+ a2u
2 + a3u
3 + · · · . (15)
The ANFs (defined in Equation 15) capture the intrinsic
nonlinearities of the underlying (BP–MCAv and PETCO2–
MCAv) relations. The cross-terms (in Equation 14) are composed
of pair products of the PDMoutputs and indicate the interactions
between BP and PETCO2 fluctuations. In the present study only
significant cross-terms are included in the final model. A cross-
term is considered significant if its correlation coefficient with the
output signal exceeds 99% significance level using the w-statistic
(derived from the Fisher transform of correlation coefficient)
(Marmarelis et al., 2012). The gain of each ANF was determined
by the slope of its best linear fit (Kang et al., 2015). This
parameter represents the linear gain coefficient of the respective
global PDM, and signifies the relative strength of a particular
contributing mechanism with a larger slope value reflecting a
stronger contribution (Marmarelis et al., 2012, 2013a). These
gains were then used as classification parameters to discriminate
between pre- and post-blockade conditions.
The optimal values for the Laguerre parameter α, the number
of Laguerre functions L, the number of global PDMs H, and
the order of ANFs were selected using Bayesian information
criteria (BIC) (Marmarelis et al., 2016). In this study, α = 0.5,
L = 5 and five global PDMs with cubic ANFs were found
to be appropriate for the BP + PETCO2 – MCAv relations
for all subjects across both groups (sympathetic blockade and
placebo) and experimental conditions (pre- and post-blockade).
The shapes of global PDMs remain similar when different (8 out
of 9) subjects were selected across one group. The robustness
of the proposed method was verified by a leave-one-subject-out
cross-validation technique where N − 1 (out of N) subjects were
used to estimate the global PDMs. Next, these estimated global
PDMs were applied to the remaining subject, and the ANFs
and corresponding gains were determined. This procedure was
repeated for all subjects.
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The first-order kernels for the BP and PETCO2 inputs
{kP, kC} were also estimated in the frequency-domain. This was
done by computing the magnitude of their discrete Fourier
transforms and calculating their spectral power by squaring
the magnitude of the respective kernel in the frequency-
domain. The second-order self-kernels {kPP, kCC} and cross-
kernel {kPC} were also determined in the frequency domain
by calculating the magnitude of their two-dimensional discrete
Fourier transforms. The kernel spectral power for frequencies
<0.03Hz was calculated by averaging the spectral power of
the respective kernel over the frequency range <0.03Hz. The
frequency limit of< 0.03Hz was chosen based on the frequency-
domain characteristics of the pressure-flow relations under
similar blockade conditions (Saleem et al., 2016) to those of the
current study.
3. RESULTS
3.1. Spontaneous Baseline Parameters
The baseline physiological parameters before and after the α1-
adrenergic receptor blockade and placebo treatment are shown
in Table 1. As reported previously (Saleem et al., 2016), no
significant condition × group interactions were found for heart
rate, BP, MCAv, PETCO2 and breathing rate, indicating that α1-
adrenergic receptor blockade changed none of these baseline
parameters as compared with the placebo treatment.
3.2. Laguerre-Volterra Kernel Analysis
The first-order kernel for BP (Figures 1A,B) resembled a high-
pass filter under pre-blockade conditions for both sympathetic
blockade (Figure 1C) and placebo groups. The α1-adrenergic
receptor blockade increased the first-order kernel spectral power
significantly (Figure 1D; p = 0.00052 for pre- vs. post-blockade
paired-t test) for the frequencies <0.03Hz, suggesting that very
low frequency BP-MCAv relations become more pronounced
after sympathetic blockade. This increase was significantly
TABLE 1 | Spontaneous baseline parameters before and after the
α1-adrenergic receptor blockade and placebo treatment.
Variable Placebo Sympathetic Interactions
Pre Post Pre Post p-values
HR (beats/min) 62± 1.9 58± 2.0 62± 2.2 63± 2.1 0.12
BP (mmHg) 73± 1.3 77± 3.6 70± 1.5 69± 1.8 0.10
MCAv (cm/s) 65± 2.4 65± 1.9 68± 3.2 64± 2.9 0.25
PETCO2 38± 1.1 37± 1.2 37± 1.2 38± 1.1 0.11
(mmHg)
Breathing rate 14.8± 0.83 12.15±1.0 12.64±1.15 13.55± 0.83 0.47
(breaths/min)
Values are mean ± standard error. HR, heart rate; Placebo, placebo treatment group;
Sympathetic, α1-adrenergic receptor blockade group. Interaction effects were determined
using linear mixed-effects models.
different from the placebo response (p= 0.00023 for condition×
group interaction). In contrast, the first-order kernel for PETCO2
resembled a low-pass filter under pre-blockade conditions in
both sympathetic blockade (Figure 2C) and placebo groups. The
α1-adrenergic blockade did not qualitatively alter the low-pass
characteristics but did reduce the magnitude significantly for the
frequencies <0.03Hz (Figure 2D; p = 0.0042 for pre- vs. post-
blockade paired-t test). This decrease was significantly different
from the placebo response (p = 0.0001 for condition × group
interaction). The average changes in spectral powers of both
BP and PETCO2 first-order kernels for frequencies <0.03Hz are
summarized in Figures 3A,C for all subjects of both groups.
Second-order self-kernels for BP before and after α1-
adrenergic receptor blockade are shown in Figure S1. Average
spectral power increased after blockade for frequencies<0.03Hz
but was not significant across all individuals (p = 0.39 for
pre- vs. post-blockade paired-t test; Figure 3B). Second-order
self-kernels for the PETCO2, shown in Figure S2, demonstrated
similar trends to the PETCO2 first-order kernels (Figure 2) but
the changes between pre- and post-blockade conditions were
not significant (p = 0.17 for pre- vs. post-blockade paired-
t test; Figure 3D) across individuals for frequencies <0.03Hz.
No significant condition × group interactions were found
for second-order BP and PETCO2 self-kernels between the
sympathetic blockade and placebo groups (Figures 3B,D).
The cross-kernels between the BP and PETCO2 before and
after sympathetic blockade are shown in Figure S3. The changes
in average spectral power associated with sympathetic blockade
were not significant (p = 0.89 for pre- vs. post-blockade paired-
t test; Figure 3E) with similar magnitude responses to placebo
(p = 0.52 for condition × group interaction). We found most
individuals did not exhibit significant cross-terms with three
exceptions (i.e., two subjects in the sympathetic blockade group,
and one subject in the placebo cohort).
Figure 4 shows scatter-plots of the logarithmic spectral
power of the first-order BP and PETCO2 kernels for
frequencies <0.03Hz for both placebo and sympathetic
blockade groups, and achieves complete separation between pre-
and post-blockade conditions of sympathetic blockade group.
3.3. Global PDM Analysis
The estimated five global PDMs from a set of eight subjects
(excluding subject 1; leave-one-subject-out cross validation) of
sympathetic blockade group are shown in Figure 5 for BP and
PETCO2 in the time- and frequency-domain. The first global
PDM for BP exhibited high-pass filter characteristics with a
blunt spectral peak at ≈0.1Hz for the sympathetic blockade
group. A spectral peak was observed at ≈0.04Hz for the 2nd
PDM, at ≈0.03Hz for the 3rd, and at ≈0.01Hz for the 5th
PDM. In contrast, the 4th PDM resembled a low-pass filter
for BP.
Similar to BP, the first global PDM for PETCO2 showed high-
pass characteristics with a blunt spectral peak at ≈0.07Hz. The
2nd, 3rd, and 5th global PDMs had spectral peaks at ≈0.04Hz,
≈0.03Hz and ≈0.01Hz, respectively. Also similar to BP, the
4th global PDM for PETCO2 showed low-pass characteristics.
The frequency patterns of global PDMs for both BP and
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FIGURE 1 | First-order kernels of the BP {kP} in the time- (upper panels) and frequency-domain (lower panels) before and after α1-adrenergic receptor
blockade, averaged over all subjects (means ± SD). (A) time-domain representation before blockade, (B) time-domain representation after blockade, (C)
frequency-domain representation before blockade, (D) frequency-domain representation after blockade.
PETCO2 were similar between placebo and sympathetic blockade
groups.
The ensemble averages of estimated cubic ANFs, using mean
coefficient values, along with their standard deviation bounds for
sympathetic blockade group under pre-blockade condition are
shown in Figure 6 for the BP and PETCO2. The ANFs of the
first global PDMs for BP were found to be almost rectilinear and
dominant over other ANFs having curvilinear characteristics.
Considerable inter-subject heterogeneity was found across ANFs
of BP, especially for the 2nd, 4th, and 5th ANFs. Positive slopes
were found for the 1st and 3rd BP ANFs across all subjects while
few (3, 6, and 5) subjects had negative slopes for the 2nd, 4th,
and 5th BP ANFs (respectively). Considerable variability across
ANFs of PETCO2 was found for all subjects with all ANFs having
curvilinear characteristics.
The estimated cubic ANFs along with their best linear fits
for one representative subject of sympathetic blockade group
are shown in Figure 7. The ANF of the first global PDM of
BP had the highest slope and is almost linear. However, other
ANFs had curvilinear characteristics with the 2nd and 3rd
showing positive trends, and the 4th and 5th showing negative
trends. In contrast to BP, all ANFs associated with PETCO2
had curvilinear characteristics with the 1st, 3rd and 4th having
positive trends, and the 2nd and 5th showing negative trends.
The ensemble averages of the estimated gains of ANFs for
the sympathetic blockade group under pre- and post-blockade
conditions are shown in Figure 8. We found no significant
changes between pre- and post-blockade conditions across all
ANFs.
To determine the relevance of interactions between BP and
PETCO2 we examined pair-products for all global PDMs. In
general pair-products were not significant across the majority
of subjects, so were not included in the final models. However,
significant pair-products were found for two subjects in
sympathetic blockade group (i.e., the global PDM 1 of BP with
the global PDM2 of PETCO2 in subject 2 before blockade, and the
global PDM 2 of BP with the global PDM 2 of PETCO2 in subject
5 after blockade) and across one subject for placebo group (i.e.,
the global PDM 1 of BP with the global PDM 4 of PETCO2 after
placebo treatment in subject 3).
We tested different combinations of ANFs for sympathetic
blockade group and found that separation of pre- and post-
blockade conditions could be attained for all subjects by using
the gains of ANFs associated with the 3rd and 4th global PDMs
for BP (Figure 9B). However, no clear separation was evident for
the pre- and post-blockade conditions of placebo treatment as
shown in Figure 9A. This observation suggests that sympathetic
nervous system may be linked with the BP global PDMs that
have low-pass (4th global PDM) and≈0.03Hz resonant peak (3th
global PDM) characteristics.
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FIGURE 2 | First-order kernels of the PETCO2 {kC} in the time- (upper panels) and frequency-domain (lower panels) before and after α1-adrenergic
receptor blockade, averaged over all subjects (means ± SD). (A) time-domain representation before blockade, (B) time-domain representation after blockade,
(C) frequency-domain representation before blockade, (D) frequency-domain representation after blockade.
4. DISCUSSION
4.1. Main Findings
This study sought to identify vascular biomarkers that could
delineate between states of intact and impaired cerebral
autoregulatory control. The proposed approach examines
CBF dynamics in response to spontaneous BP and PETCO2
fluctuations using Laguerre-Volterra kernels based PDM
analysis. This methodology makes use of global PDMs derived
from the first- and second-order kernels, and the linear gains
of their ANFs. We found that the mutual coupling of linear
components (i.e., first-order kernels) of the BP and PETCO2
for frequencies <0.03Hz could detect the cerebrovascular
effects of α1-adrenergic blockade. Moreover, in keeping with
our hypothesis, the gains of ANFs associated with the very
low frequency global PDMs (having low-pass and ≈0.03Hz
peak characteristics) for BP could clearly discriminate between
the baseline and blockade states. Collectively these findings
suggest that global PDMs and ANFs may have potential utility as
biomarkers of sympathetic cerebrovascular dysfunction.
4.2. Modeling with Laguerre-Volterra
Kernels and Global PDMs
Volterra formulation of kernels represents the system output
in terms of linear and nonlinear interactions between different
input(s), as well as between lagged epochs within a given set
of input(s). The linear interactions are quantified by the first-
order kernel representing the linear component (similar to the
impulse response) of the system (Panerai et al., 1999; Marmarelis
et al., 2012; Angarita-Jaimes et al., 2014). In contrast, the
nonlinear interactions are summarized by second-order kernels,
which reflect the interactions between different epochs within
a respective input (i.e., self-kernels) or interactions among the
different epochs of two inputs (i.e., cross-kernels) (Marmarelis
et al., 2012). The spectral representation of the second-order
kernels reflects the nonlinear interactions between frequency-
dependent dynamics of the respective input(s) (Mitsis et al.,
2002). The diagonal entries (of the frequency spectrum of the
second-order kernel) reflect nonlinear physiological processes
operating within the respective frequencies while the off-diagonal
entries reflect nonlinear intermodulatory interactions among
different mechanisms that operate at different frequencies (Mitsis
and Marmarelis, 2002; Mitsis et al., 2002).
In this study a fusing procedure, via singular value
decomposition, was applied to the estimated Laguerre-Volterra
kernels from an ensemble of subjects to obtain a minimal
set of basis functions. As these global PDMs are common
to all subjects, they form a compact representation of
individual’s system dynamics (Marmarelis et al., 2013b; Angarita-
Jaimes et al., 2014). To complete the nonlinear PDM-
based model, the static nonlinearities associated with each
global PDM are captured in the form of subject-specific
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FIGURE 3 | Changes in spectral powers of (A) first-order BP kernel {kP}, (B) second-order BP self-kernel {kPP}, (C) first-order PETCO2 kernel {kC}, (D)
second-order PETCO2 self-kernel {kCC}, and (E) cross-kernel between BP and PETCO2 {kPC} before and after α1-adrenergic receptor blockade and placebo
treatment for frequencies <0.03Hz. *p<0.05 represents a significant two-way (condition × group) interaction between placebo and sympathetic blockade groups.
FIGURE 4 | Scatter-plots of logarithmic spectral power of first-order BP {kP} and PETCO2 {kC} kernels for frequencies <0.03Hz for (A) placebo
treatment, (B) sympathetic blockade. The classification curve in subplot (B) has been obtained using a linear discriminator.
ANFs which can be used to distinguish the dynamics of
individual subjects. Recent studies (Angarita-Jaimes et al.,
2014) have shown that the compact formulation of “global”
PDMs reduces the inter-subject variability and the subject-
specific ANFs capture the intra-subject variance across repeated
recordings.
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FIGURE 5 | The five global PDMs for the BP (left panels) and PETCO2 (right panels) of the dual-input (BP + PETCO2 – MCAv) models of sympathetic blockade
group in the time- (upper panels) and frequency-domain (lower panels).
FIGURE 6 | The ensemble averages of estimated ANFs along with their standard deviation bounds for the sympathetic blockade group under
pre-blockade conditions for the BP (upper panels) and PETCO2 (lower panels). The solid lines represent means and dotted lines represent standard deviation
bounds.
The robustness of the global PDMs (determined by the leave-
one-subject-out cross-validation) shows that the apparent shape
of global PDMs does not change when a different combination
of participants (i.e., 8 out of 9) is chosen for one group. Our
findings are consistent with previous studies (Marmarelis et al.,
2013a) showing that the characteristic features of global PDMs do
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FIGURE 7 | The estimated ANFs for subject 1 of sympathetic blockade group corresponding to the five global PDMs (shown in Figure 5) for the BP
(upper panels) and PETCO2 (lower panels), along with their best linear fits (red line).
FIGURE 8 | The ensemble averages of estimated gains of ANFs for the sympathetic blockade group under pre- and post-blockade conditions for the
BP (upper panels) and PETCO2 (lower panels). Errors bars represent means ± SD.
not vary appreciably when different subsets of reference subjects
were chosen to extract global PDMs. Although global PDMs are
common for all subjects of both groups, the ANFs associated
with each global PDM are subject-specific and have the ability
to uniquely characterize the dynamics of each subject.
4.3. Physiological Interpretation of
Laguerre-Volterra Kernels and Global
PDMs
In general the physiological origins of the observed principal
dynamic modes are not well understood but several plausible
explanations should be considered. The linear dynamics
of BP represented by its first-order kernel have high-pass
characteristics. This indicates that slow BP fluctuations are more
effectively attenuated than higher frequency BP fluctuations
and a plausible biophysical model that could account for
these dynamics is the arterial Windkessel (Zhang et al.,
2009). In contrast, the first-order kernel for PETCO2 has
low-pass characteristics suggesting that very slow PETCO2
fluctuations have a pronounced effect on MCAv dynamics.
These observations are consistent with studies showing that
CO2 modulation of cerebrovasculature occurs with a slow
dynamic time constant under spontaneous baseline conditions
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FIGURE 9 | Scatter-plots of estimated gains of ANFs corresponding to the 3th and 4th global PDMs for the BP for pre- and post-blockade conditions
of (A) placebo treatment, and (B) sympathetic blockade group. The classification curve in subplot (B) has been obtained using a linear discriminator.
Leave-one-subject-out cross-validation technique was adopted to derive the global PDMs and the corresponding ANFs.
(Ainslie and Duffin, 2009; Peebles et al., 2012). Most of
the spectral power of the second-order (self and cross)
kernels are concentrated at frequencies <0.03Hz suggesting
that significant intermodulatory interactions between BP and
PETCO2 fluctuations are found across very low frequencies
(<0.03Hz). In keeping with this interpretation, our ability to
separate between pre- and post-blockade states of α1-adrenergic
group was optimal when we considered both BP and PETCO2
kernels for frequencies <0.03Hz using a two-dimensional
separation regime (Figure 4B).
It has previously been suggested that the distinct spectral
characteristics of global PDMs may carry functional information
about specific physiological mechanisms (Marmarelis et al., 2012,
2013a). Our analyses show that the first global PDM for BP has
high-pass characteristics having spectral peak at≈0.1Hz. Similar
to the first-order kernel, we speculate that this feature may relate
to theWindkessel properties of the vasculature. The large positive
value of linear gain coefficient of its ANF indicates that this
component may be an influential determinant of CBF dynamics.
In contrast, the 4th global PDM has low-pass characteristics with
a cut-off frequency of ≈0.025Hz indicating the integration of
the BP input over several seconds. Speculatively, this feature
may reflect the activity of neurogenic or humoral blood pressure
control mechanisms that operate with a slow dynamic time
constant (Ursino and Magosso, 2004). The 2nd, 3rd, and 5th
global PDMs have complex spectral patterns with spectral peaks
at ≈0.04, ≈0.03, and ≈0.01Hz, respectively. The physiological
origins of these components are unclear but our data suggests
that sympathetic cerebrovascular control may contribute to the
3rd and 4th global PDMs since their linear gain coefficients were
affected following sympathetic blockade.
The global PDMs for PETCO2 exhibit spectral characteristics
that were similar to BP with the first global PDM also showing
high-pass characteristics with a spectral peak at ≈0.07Hz. The
4th global PDM shows low-pass characteristics with a half-max
frequency of ≈0.01Hz indicating the integration of the PETCO2
over several seconds. It has been suggested that this component
might be sensitive under hypo- or hyper-ventilation conditions
(Marmarelis et al., 2012). Consistent with one previous study
(Mitsis et al., 2006), we observed that a significant portion of
the PETCO2 power resides within the very-low frequencies of this
low-pass global PDM. Similar to BP, the 2nd, 3rd, and 5th global
PDMs also have complex spectral patterns with resonant peaks at
≈0.04, ≈0.03, and ≈0.01Hz, respectively. However, in contrast
to BP, α1-adrenergic blockade did not affect these components
suggesting that PETCO2 global PDMs may not be mediated by
sympathetic activity.
An interesting observation was that the resonant peaks of BP
and PETCO2 global PDMs occurred at common frequencies. This
might occur as a result of BP and PETCO2 fluctuations engaging
common vascular control mechanisms. Though the exact nature
of these interactions is not well understood, the general absence
of significant cross-terms between BP and PETCO2 shows that
their effects on cerebrovasculature might be independent of each
other (Marmarelis et al., 2012, 2013a). It is also important to
note that significant changes after placebo treatment occurred
in a few subjects. This observation suggests that there are time
dependent effects in cerebral hemodynamics consistent with a
non-stationary system. Such changes highlight the importance
of including placebo group in the design of experimental studies
involving multiple measurements across time.
4.4. Implications
The findings of the present study have important methodological
implications. The spectral assessment of cerebral hemodynamics
is often performed within predefined continuous frequency
ranges that were originally based on simple transfer function
analysis (Zhang et al., 1998). However, the current literature lacks
the experimental verification of these bands. There is growing
evidence that CBF dynamics within the VLF range is an amalgam
of many redundant physiological processes that individually may
only contribute to a sub-component of this predefined frequency
range. Indeed, in a recent study using wavelet decomposition
analysis we showed that sympathetic blockade altered the phase
synchronization between BP and MCAv within the 0.02–0.03 Hz
range (Saleem et al., 2016). Here we demonstrate that within
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this range, α1-adrenergic blockade affected only global PDMs
having low-pass and ≈0.03Hz resonant peak characteristics.
These findings also prompt the development and potential
application of filter banks that can characterize and quantify
cerebral haemodynamics along a wide array of narrow-band
frequency scales.
4.5. Methodological Considerations
Several experimental and methodological limitations need to
be considered for interpretation of the findings of this study.
First, CBF dynamics were assessed using TCD, which estimates
intracranial blood velocity in the middle cerebral artery instead
of the volumetric flow. However, intracranial blood velocity can
be used as an adequate surrogate of actual blood flow only when
the diameter of the insonated vessel remains unchanged under
different haemodynamic conditions. This assumption is generally
met under normocapnic conditions (Serrador et al., 2000;
Coverdale et al., 2014) but other complementary monitoring
techniques such as near-infrared spectroscopy can be used in
future studies to provide surrogates of blood volume and cortical
oxygenation.
Second, we acknowledge that the duration of recorded time
series can affect the model estimation. However, the 6 min
recordings examined in the present study were of comparable
duration to those of previous studies employing Laguerre-
Volterra kernels and global PDM-based models for cerebral
haemodynamic characterization (Mitsis et al., 2009; Marmarelis
et al., 2012, 2013a). The adopted methodology in the present
study requires 66 free parameters from a data record of 6
min, satisfying the conventional rule of thumb that the number
of independent data samples should be ≈5 times as many as
the estimated free parameters to avoid overfitting. It has been
observed that the number of free parameters can be reduced to
41 if a Laguerre-Volterra Network having five hidden units is
adopted (Marmarelis, 2004). Moreover, the selection of different
values of α, and the number of Laguerre functions (i.e., L) for
each input have been reported resulting in (1) the higher value
of α (for example, 0.85 in Marmarelis et al., 2016), and (2) the
less number of Laguerre functions for the PETCO2 input than
that of the BP input. The increased α and reduced L value lead to
longer kernel memory and less number of free parameters in the
model, respectively, thereby improving the estimation accuracy
of the kernels from short recorded data lengths.
Third, the proposed functional biomarkers have been
developed based on an open-loop model of cerebral circulation
with BP and PCO2 as driving inputs and CBF as an output.
However, recent studies suggest that there may also be reverse
information flow from CBF to BP, suggesting that cerebral
haemodynamic characterization may be further improved using
closed-loop models (Marmarelis et al., 2013a). In relation to this
point, since CBF regulation is a multifaceted process mediated
by various physiological variables, future studies should also
consider the role of additional inputs to the cerebrovascular
system such as cardiac output (Marmarelis et al., 2016). Finally,
the present study showed that α1-adrenergic blockade altered the
3rd and 4th global PDMs suggesting that sympathetic activity
may underlie these global PDMs. However, our findings do not
preclude the possibility that other mechanisms (e.g., cholinergic,
myogenic, metabolic factors) may also be contributing to these
PDM components.
5. CONCLUSION
In summary, very low frequency (<0.03Hz) dynamics of
CBF regulation in response to spontaneous BP and PETCO2
fluctuations are associated with the human sympathetic
modulation. Moreover, the linear gains of ANFs of very
low frequency (<0.03Hz) global PDMs may be used as
autoregulatory biomarkers to determine the impairment of
human sympathetic control.
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